Study #2015-0052
Phase I Trial of Radiation Therapy In Patients With Liver Cancers and Impaired Liver Function
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This phase I trial studies the side effects and the best dose of radiation therapy in treating patients with hepatocellular carcinoma, cholangiocarcinoma, or cancer that has spread from the original (primary) tumor to the liver who also have impaired liver function (liver damage caused by cirrhosis, chemotherapy, or surgery). Radiation therapy (RT) uses high energy x-rays to kill tumor cells and shrink tumors. New methods of giving RT to the liver may help control cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Cholangiocarcinoma;Cirrhosis;Hepatocellular Carcinoma;Metastatic Malignant Neoplasm in the Liver
Study phase:
Phase I
Physician name:
Eugene Koay
Department:
Radiation Oncology
For general questions about clinical trials:
1-855-773-0951
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.